Table 3.
Effect of ARV therapy on CD4 counts after 12 months.
| BASELINE CD4 (cells/mm3) | DELTA CD4 after 12 months | ||||||||
| Mean | Median | Interval | Mean | Median | Interval | ||||
| Non-treated (N = 10) | 402 | 427 | 193 | 660 | -16 | -21 | -112 | 64 | |
| ARV therapies (n = 22) | 263 | 226 | 10 | 737 | 64 | 50 | -62 | 323 | |
| - with PIs (n = 15) | 230 | 237 | 10 | 527 | 106 | 89 | -31 | 323 | p = 0,0003 |
| - without PIs (n = 7) | 333 | 195 | 150 | 737 | -25 | -53 | -62 | 57 | |
| - undetectable VL (n = 8) | 248 | 195 | 40 | 630 | 137 | 141 | 12 | 323 | p < 0,0001 |
| - detectable VL (n = 14) | 272 | 226 | 10 | 737 | 23 | 16 | -62 | 180 | |
Interval columns give minimum and maximum CD4 cells/mm3. N is the number of patients for the untreated group, and n is the number of therapies in the treated group. p values were obtained by the analysis of variances using a Tukey test (see Methods section). PI = protease inhibitor, VL = plasma viral load.